Cardlytics (CDLX) Stock Falls on Q4 2025 Earnings

Cardlytics Inc. (CDLX) reported fourth-quarter 2025 results with revenue of $56.1 million and a diluted EPS of -0.15.

Revenue: $56.1 million, down 24.2% year-over-year and slightly above the estimate of $55.5 million.

Gross profit: $25.9 million, down 20.9% year-over-year.

Operating result: operating loss of $6.1 million, a 26.7% year-over-year decline.

Net result: net loss attributable to common shareholders of $8.25 million, down 47.1% year-over-year.

Diluted EPS of -0.15 versus an estimate of -0.0714.

Cash from operating activities: $13.0 million, up 336.7% year-over-year.

Capital spending: purchases of property, plant and equipment of $25,000, down 79.7% year-over-year.

Cash and cash equivalents: $48.7 million, down 25.7% year-over-year.

Total liabilities: $292.1 million, down 9.5% year-over-year.

Shares fell about 5.0% after the market close.

In short, Cardlytics delivered a slight revenue beat and a sharp improvement in operating cash flow, while profitability metrics remained negative and EPS missed the estimate for the quarter.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Cardlytics Inc. Insider Trading Activity

Cardlytics Inc. insiders have traded $CDLX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $CDLX stock by insiders over the last 6 months:

AMIT GUPTA (Chief Executive Officer) has made 0 purchases and 4 sales selling 110,814 shares for an estimated $113,271.
ALEXIS DESIENO (Chief Financial Officer) has made 0 purchases and 2 sales selling 17,100 shares for an estimated $29,357.
NICHOLAS HOLLMEYER LYNTON (Chief Legal & Privacy Officer) has made 0 purchases and 2 sales selling 12,351 shares for an estimated $21,164.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Cardlytics Inc. Hedge Fund Activity

We have seen 26 institutional investors add shares of Cardlytics Inc. stock to their portfolio, and 76 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAS INVESTMENT PARTNERS, LLC removed 5,198,067 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,977,777
MIRABELLA FINANCIAL SERVICES LLP removed 1,155,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,806,650
LANE GENERATIONAL LLC removed 780,083 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,895,601
JACOBS LEVY EQUITY MANAGEMENT, INC added 638,617 shares (+inf%) to their portfolio in Q4 2025, for an estimated $734,409
QUINN OPPORTUNITY PARTNERS LLC removed 637,598 shares (-58.0%) from their portfolio in Q4 2025, for an estimated $733,237
MORGAN STANLEY removed 484,393 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $557,051
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. removed 400,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $972,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.